Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates

Simply Wall St.01:21

Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614741807?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-02-25 01:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614741807","market":"nz","top_or_hot":-1,"title":"Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates","media":"Simply Wall St.","content":"<div>\n<p>Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/insulet-expands-buyback-as-shares-trade-below-analyst-and-fa\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsulet Expands Buyback As Shares Trade Below Analyst And Fair Value Estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 01:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/insulet-expands-buyback-as-shares-trade-below-analyst-and-fa><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/insulet-expands-buyback-as-shares-trade-below-analyst-and-fa\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2065171402.SGD","symbol_name":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/insulet-expands-buyback-as-shares-trade-below-analyst-and-fa","article_id":"2614741807","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-podd/insulet/news/insulet-expands-buyback-as-shares-trade-below-analyst-and-fa","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614741807","pubTimestamp":1771953688,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization.\nThe company also extended the duration of its equity repurchase program, giving management more time to execute on the plan.\nThe expanded authorization and longer timeline point to ongoing efforts to return capital to shareholders through repurchases.\n\nFor investors watching NasdaqGS:PODD, the buyback update comes as the stock trades around $249.38. Recent performance has been mixed, with a 2.7%...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","BK4588":"碎股","BK4585":"ETF&股票定投概念","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","PODD":"银休特","BK4551":"寇图资本持仓","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK4082":"医疗保健设备","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0728928796.USD":"abrdn SICAV I - GLOBAL SMALL&MID-CAP SDG HORIZONS EQUITY \"A\" (USD) ACC","BK4566":"资本集团"},"translate_title":"由于股价交易低于分析师和公允价值预期，Insulet扩大回购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PODD":1.5},"content_text":"Insulet, NasdaqGS:PODD, has approved a significant increase in its share buyback authorization. The company also extended the duration of its equity repurchase program, giving management more time to execute on the plan. The expanded authorization and longer timeline point to ongoing efforts to return capital to shareholders through repurchases.  For investors watching NasdaqGS:PODD, the buyback update comes as the stock trades around $249.38. Recent performance has been mixed, with a 2.7% gain over the past week but a 30-day return showing an 8.2% decline, and declines of 11.9% year to date and 12.0% over the past year. These moves frame the context in which management is choosing to commit more capital to repurchases. The larger and longer buyback program signals that Insulet sees value in retiring its own shares and is prepared to allocate cash accordingly. For you as a shareholder or potential investor, the key question is how this fits with your view of the company’s long-term prospects, its balance between growth investment and cash returns, and your comfort with its recent return profile. Stay updated on the most important news stories for Insulet by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Insulet. NasdaqGS:PODD Earnings & Revenue Growth as at Feb 2026 Is Insulet's dividend sustainable? Check out what every dividend investor needs to know in our dividend analysis. AdvertisementQuick Assessment  ✅ Price vs Analyst Target: At $249.38, Insulet trades about 30% below the US$354.40 analyst price target range midpoint. ✅ Simply Wall St Valuation: Simply Wall St estimates the shares are trading 16.1% below fair value, suggesting potential valuation support for buybacks. ❌ Recent Momentum: The 30 day return of 8.2% means the buyback news is arriving after a soft recent share price patch.  There is only one way to know the right time to buy, sell or hold Insulet. Head to Simply Wall St's\ncompany report for the latest analysis of Insulet's Fair Value. Key Considerations  📊 A larger and longer buyback program concentrates future returns among remaining shareholders if it is executed at prices management views as attractive. 📊 Keep an eye on buyback execution versus cash generation, the 71.0x P/E relative to the 30.9x industry average, and any updates to analyst price targets. ⚠️ Profit margins at 9.1% are below last year's 20.2%, and one off items have affected results, so you may want to check that repurchases do not crowd out reinvestment needs.  Dig Deeper For the full picture including more risks and rewards, check out the\ncomplete Insulet analysis. Alternatively, you can check out the\ncommunity page for Insulet to see how other investors believe this latest news will impact the company's narrative.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614741807","isCrawlerRequest":true}